"Insights about how one type of cancer relates to another form of the disease can have real clinical implications," said Josh Stuart, Baskin Professor of Biomolecular Engineering at UC Santa Cruz and an organizer of the Pan-Cancer Initiative. "In some cases, we can borrow clinical practices from bet
Date: Apr 05, 2018
Category: Health
Source: Google
Therapeutic options of patients can be improved by new cancer classification ...
The classification of only 10 percent was done differently, but it matters a lot if one is among those patients, stated a professor of biomolecular engineering at UC Santa Cruz and senior author, Josh Stuart.
Date: Aug 10, 2014
Category: Health
Source: Google
New Cancer Classification System Offers More Accurate Diagnoses
"It's only ten percent that were classified differently, but it matters a lot if you're one of those patients," said senior author Josh Stuart, a professor of biomolecular engineering at UC Santa Cruz.
Date: Aug 10, 2014
Category: Health
Source: Google
New cancer classification system may revolutionize diagnoses and treatments
"As we looked at more and more tumor types, it became clear that there were some subsets of tumors that reminded us of a subset we analyzed last year," said Josh Stuart, a biomolecular engineer at UC Santa Cruz who oversaw the study. "It was obvious that we should start comparing across tumor types.
Date: Aug 10, 2014
Source: Google
UCSC researchers contribute to detailed ovarian cancer analysis
UCSC researchers David Haussler, professor of biomolecular engineering, and Josh Stuart, associate professor of biomolecular engineering, both contributed to the study. Their work focused on understanding the molecular pathways in the cell that are disrupted in ovarian cancer.A pathway is a collection of genes that talk to each other in the cell," Haussler said in a statement. "Josh Stuart did the analysis to see whether certain pathways were characteristically disrupted in ovarian cancer, and he found one very strong pathway that is disrupted in advanced ovarian cancer.